Imaging devices fail to pick up RNFL defects

Article

Various imaging devices fail to identify localized retinal nerve fibre layer (RNFL) defects, according to a study published in the January issue of the British Journal of Ophthalmology.

Various imaging devices fail to identify localized retinal nerve fibre layer (RNFL) defects, according to a study published in the January issue of the British Journal of Ophthalmology.

Dr M T Nicolela of the Eye Care Center, Nova Scotia, Canada and colleagues had three masked observers assess eyes (51 with RNFL defects visible on optic disc photographs and 51 control) with confocal scanning laser tomography (CSLT), scanning laser polarimetry (SLP) and optical coherence tomography (OCT) to establish which device provided a more accurate image of localized damage.

The observers had the greatest degree of agreement of RNFL defect as displayed on OCT (kappa, 0.83), followed by SLP (0.69) and CSLT (0.64). At least two oberserves identified RNFL defects in 58.8%, 66.7% and 54.9% of images from CSLT, SLP and OCT, respectively. With CSLT, SLP and OCT, the observers rated 94.1%, 84.3% and 94.1%, respectively, of control eyes as normal.

The researchers deduced that between 20% and 40% of RNFL defects shown on colour optic disc photographs fail to be identified by CSLT, SPL or OCT. Of all three methods, SLP had the highest rate of both false-positives and correct RNFL defect identification.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.